{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:02:57Z","timestamp":1746511377673},"reference-count":44,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T00:00:00Z","timestamp":1289692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> The aim of this study was to investigate the prevalence of resistances in <jats:italic>Helicobacter pylori<\/jats:italic> against commonly used antibiotics including metronidazole, clarithromycin, amoxicillin, and tetracycline in Iranian patients.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>  <jats:italic>H.\u00a0pylori<\/jats:italic> isolates were collected from gastric biopsies from patients referred for upper gastrointestinal endoscopy at Tooba Medical Center, Sari, Iran, from 2007 to 2010. None of them had been using antibiotics for at least 8\u2003months. <jats:italic>H.\u00a0pylori<\/jats:italic> was identified based on morphological shape and positive biochemical tests for catalase, oxidase, and urease activity. Antibiotic resistance for metronidazole, clarithromycin, amoxicillin, and tetracycline was investigated by using epsilometer test. Resistance was defined by minimal inhibitory concentration (MIC)\u2003&gt;\u20030.5\u2003mg\/L for amoxicillin (AMX), &gt;4\u2003mg\/L for tetracycline (TET), &gt;8\u2003mg\/L for metronidazole (MTZ), and &gt;1\u2003mg\/L for clarithromycin (CLR).<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Strains were collected from 132 patients, mean age 45.8\u2003years, 52 (39%) were women. Patients had diverse diagnoses: gastritis 42 (31.8%), duodenal ulcer 45 (34%), gastric cancer 15 (11.3%), or gastric ulcer 30 (22.7%). The prevalences of resistance of <jats:italic>H.\u00a0pylori<\/jats:italic> strains isolated from the patients were 73.4% for metronidazole, 30% for clarithromycin, 6.8% for amoxicillin, and 9% for tetracycline. Twenty\u2010eight (21.2%) were double resistant to MTZ\u2010CLR, 16 (12.1%) showed triple resistance to MTZ\u2010CLR\u2010AMX, and 8 (6%) were resistant to all four tested antibiotics (MTZ\u2010CLR\u2010AMX\u2010TET). No associations were detected between multiple resistant strains and clinical manifestations (<jats:italic>p<\/jats:italic>\u2003&gt;\u2003.05).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The prevalence of <jats:italic>H.\u00a0pylori<\/jats:italic> antibiotic resistance to metronidazole and clarithromycin was high in Iran consistent with the reported low success rates for <jats:italic>H.\u00a0pylori<\/jats:italic> treatment in this country.<\/jats:p>","DOI":"10.1111\/j.1523-5378.2010.00795.x","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T05:08:56Z","timestamp":1289797736000},"page":"505-509","source":"Crossref","is-referenced-by-count":34,"title":["Antibiotic Resistance of <i>Helicobacter pylori<\/i> in Mazandaran, North of Iran"],"prefix":"10.1111","volume":"15","author":[{"given":"Amin","family":"Talebi Bezmin Abadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf M.","family":"Mobarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarang","family":"Taghvaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Wolfram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,14]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90929-4"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa001999"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2008.068346"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520010077036"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-9-705"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1001110"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2009.00738.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.02.007"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-006-0143-1"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01396.x"},{"key":"e_1_2_7_12_2","first-page":"39","article-title":"A Sero epidemiological study of Helicobacter pylori infection in Sari","volume":"12","author":"Babamahmoodi B","year":"2004","journal-title":"JMMS"},{"key":"e_1_2_7_13_2","first-page":"576","article-title":"Gastric cancer in Iran: epidemiology and risk factors","volume":"12","author":"Malekzadeh R","year":"2009","journal-title":"Arch Iran Med"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350070003"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2002.00435.x"},{"key":"e_1_2_7_16_2","volume-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria","author":"National Committee for Clinical Laboratory Standards","year":"1997"},{"key":"e_1_2_7_17_2","unstructured":"Agar Dilution Susceptibility Test Procedure Approved at the Subcommittee Level. Tampa Florida: January 13 1998."},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70101-5"},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.5897\/AJB2010.000-3015","article-title":"Increasing trend of metronidazole resistance in the treatment of Helicobacter pylori infection: a global challenge","volume":"9","author":"Novesti B","year":"2010","journal-title":"Afr J Biotechnol"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.4167\/jbv.2008.38.4.173"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0303.970320"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.3748\/wjg.v11.i38.6009","article-title":"Helicobacter pylori antibiotic resistance in Iran","volume":"7","author":"Mohammadi M","year":"2005","journal-title":"World J Gastroenterol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000058009"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.4.511"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-49-5-415"},{"key":"e_1_2_7_26_2","first-page":"448","article-title":"The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate\u2010 vs. omeprazole\u2010based one\u2010week triple therapies in Helicobacter pylori eradication\u2010a randomised controlled trial","volume":"114","author":"Bago J","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_2_7_27_2","first-page":"685","article-title":"An overview of antimicrobial resistance and the future of medicinal plants in the treatment of Helicobacter pylori infections","volume":"3","author":"Njume C","year":"2009","journal-title":"Afr J Pharm Pharmacol"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2010.00753.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00265-2"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01068.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2009.00737.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.t01-1-07288.x"},{"key":"e_1_2_7_33_2","first-page":"286","article-title":"Furazolidone antimicrobial effectiveness against metronidazole resistant strains of Helicobacter pylori","volume":"12","author":"Alizadeh RS","year":"2006","journal-title":"East Mediterr Health J"},{"key":"e_1_2_7_34_2","first-page":"308","article-title":"Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children","volume":"9","author":"Siavoshi F","year":"2006","journal-title":"Arch Iran Med"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2008.02062.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.39628"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.182.11.3219-3227.2000"},{"key":"e_1_2_7_38_2","first-page":"436","article-title":"Clinicopathological assessment of gastric biopsy samples of patients with helicobacter pylori infection metronidazole resistance and compliance problems in the United Arab Emirates","volume":"24","author":"Adeyemi EO","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i5.671"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-007-0543-6"},{"key":"e_1_2_7_41_2","first-page":"174","article-title":"Genetic diversity and drug resistance of Helicobacter pylori strains in Isfahan, Iran","volume":"11","author":"Khashei R","year":"2008","journal-title":"Iranian J Basic Med Sci"},{"key":"e_1_2_7_42_2","first-page":"181","article-title":"Experiences with Helicobacter pylori treatment in Iran","volume":"31","author":"Saberi\u2010Firoozi M","year":"2006","journal-title":"Iranian J Med Sci"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00931.x"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.1.121"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.35.7.1842-1846.1997"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1523-5378.2010.00795.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1523-5378.2010.00795.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:19:24Z","timestamp":1698664764000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1523-5378.2010.00795.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,14]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1523-5378.2010.00795.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-5378.2010.00795.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,14]]}}}